InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures
Go back to InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures| INSPIREMD, Inc. (NASDAQ: NSPR) | Delayed: 0.72 +0.01 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $3.35 | |||
| Open | $0.72 | 52 Week Low | $0.07 | |||
| Day High | $0.77 | P/E | N/A | |||
| Day Low | $0.72 | EPS | $-0.96 | |||
| Volume | 96,077 | |||||
